ACTIVE INGREDIENT: Ranitidine Hydrochloride
STRENGTH, PACK SIZE & GMS CODES:
150 mg Tablets x 60 ~ 43051
300 mg Tablets x 30 ~ 43147
In the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Prevention of non-steroidal anti-inflammatory drug (including aspirin) associated duodenal ulcers, especially in patients with a history of peptic ulcer disease. Also indicated for the treatment of reflux oesophagitis, post-operative ulcer, Zollinger-Ellison Syndrome and other conditions where reduction of gastric acid secretion is likely to be beneficial.
Children (3 to 18 years)
• Short term treatment of peptic ulcers
• Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastrooesophageal reflux disease.